Ola Tuvesson | CTO
NorthX Biologics

Ola Tuvesson is a seasoned professional in the field of biotechnology and vaccine development, currently serving as the Chief Technology Officer at NorthX Biologics. With over 20 years of experience in the industry, Ola has a proven track record of supporting successful biologics programs ranging from development to commercial GMP manufacturing for the global vaccine industry.

Throughout his career, Ola has a strong commitment to innovation and strategic partnerships, driving the advancement of technologies and solutions in the biologics sector, supporting the realisation of scienctific advancements into tangible and compliant products that can make an actually difference. 

As a speaker at the World Vaccine Congress Europe 2026, Ola Tuvesson brings a wealth of knowledge and insights on research, development, and strategic partnering in the bioogics and vaccine industry. His expertise and thought leadership are invaluable assets in driving the conversation around the future of vaccine innovation and the importance of collaboration in addressing global health challenges.